ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631371; 2) Community: the network communities that were significantly associated with the response to NSC 631371; 3) Molecule: the relationships between components within communities and NSC 631371; 4) MDR: the compounds that were significantly associated with the NSC 631371.

NSC Compound Enrichment Correlation
NSC 700252 meso-2,6-diaminopimelyl-(D)-methyl ester-(L)-L-alanyl-D-iso glutamyl-[N'-(2-aminoethyl)-2-aminoethyl]-4-nitro-9-aminoacridine, dihydrochloride 0.00163653239752573 0.11956482
NSC 720340 Null 0.00163653239752573 0.28835689
NSC 726902 Null 0.00163653239752573 0.42060871
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00163653239752573 0.50282208
NSC 737222 Null 0.00163653239752573 0.16592205
NSC 756471 SB-732941 0.00163653239752573 0.56954567
NSC 763198 Null 0.00163653239752573 0.49550502
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.00172065213317242 0.25628784
NSC 682756 Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- 0.00172065213317242 -0.21685957
NSC 714655 Null 0.00172065213317242 0.15157999
Total:127  Current:13    [First] [Prev] [Next] [Last]